ChemoGel - A thermoresponsive hydrogel for interventional oncology applications Licensing Opportunity from RCSI June 2017 front page preview

ChemoGel - A thermoresponsive hydrogel for interventional oncology applications Licensing Opportunity from RCSI June 2017

Thermoresponsive hydrogels have attracted significant attention for drug delivery due to their ability to phase-transition from an injectable liquid at room temperatures to a solid gel at physiological temperatures. Howe...

pdf 507.4KB

Crohn’s Disease Diagnostic - Licensing Opportunities for Maynooth University - September 2017 front page preview

Crohn’s Disease Diagnostic - Licensing Opportunities for Maynooth University - September 2017

Inflammatory bowel disease (IBD) splits into 2 major types of disease; Crohn’s disease (CD) and ulcerative colitis (UC). The definitive distinction between CD and UC is challenging and generally relies on a combination ....

pdf 42.4KB

We have developed novel biosensors to selectively monitor neurochemicals in the living brain on a timescale from milliseconds to days. The sensors are used to understand the complex functioning of the brain in terms of b... front page preview

We have developed novel biosensors to selectively monitor neurochemicals in the living brain on a timescale from milliseconds to days. The sensors are used to understand the complex functioning of the brain in terms of b...

The Centre for Ocean Energy Research (COER) at Maynooth University has core strengths in mathematical modelling, control systems, prognostics and optimization – all focused on ocean energy research. The Centre collaborat...

pdf 41.8KB

Biomarker Sensors - Licensing Opportunities for Maynooth University for September 2017 front page preview

Biomarker Sensors - Licensing Opportunities for Maynooth University for September 2017

We have developed novel biosensors to selectively monitor neurochemicals in the living brain on a timescale from milliseconds to days. The sensors are used to understand the complex functioning of the brain in terms of b...

pdf 42KB

Small Molecule Therapies for Inflammatory Bowel Disease - Licensing Opportunity for Maynooth University for September 2017 front page preview

Small Molecule Therapies for Inflammatory Bowel Disease - Licensing Opportunity for Maynooth University for September 2017

The incidence of inflammatory bowel disease (IBD) is rising globally with an especially large increase in children. We have developed small molecules with strong anti-inflammatory effects in cell based models, with poten...

pdf 42.4KB